Výsledky vyhledávání - "Wolfgang, Hueber"

Akademický článek

Development and testing of an alternative responder definition for EULAR Sjögren’s Syndrome Patient Reported Index (ESSPRI)

Autor: Simon Bowman, Wolfgang Hueber, Samantha Wratten, Linda Abetz-Webb, Ethan Arenson, Pip Griffiths, Briana Ndife, Daniel Kuessner, Pushpendra Goswami

Publikováno v: RMD Open, Vol 9, Iss 1 (2023)

Objectives Dryness, fatigue and joint/muscle pain are typically assessed in Sjögren’s trials using European Alliance of Associations for Rheumatology Sjögren’s Syndrome Patient Reported Index (ESSPRI). A Patient Acceptable Symptom State of 90%)

Externí odkaz: https://doaj.org/article/ec6deec80b344146b3e256f90fec7ebe

Zobrazit plný text záznamu

Content Validity of Sjögren's Syndrome Symptom Diary and Functional Assessment of Chronic Illness Therapy-Fatigue in Patients with Sjögren's

Autor: Natasha Griffiths, Samantha Wratten, Jessica Flynn, Arthur A. M. Bookman, Briana Ndife, Wolfgang Hueber, Pushpendra Goswami

Publikováno v: Rheumatology and therapy. 9(6)

Sjögren's Syndrome Symptom Diary (SSSD) and Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) are patient-reported outcome (PRO) instruments assessing Sjögren's symptoms. Original SSSD items have demonstrated content validity, howe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::598a3fe9a5dfd7bdec7cc69c59397cfb
https://pubmed.ncbi.nlm.nih.gov/36152275

Zobrazit plný text záznamu

Plný text ve formátu HTML

Development and preliminary validation of the Sjögren’s Tool for Assessing Response (STAR): a consensual composite score for assessing treatment effect in primary Sjögren’s syndrome

Autor: Raphaele, Seror, Gabriel, Baron, Marine, Camus, Divi, Cornec, Elodie, Perrodeau, Simon J, Bowman, Michele, Bombardieri, Hendrika, Bootsma, Jacques-Eric, Gottenberg, Benjamin, Fisher, Wolfgang, Hueber, Joel A, van Roon, Valérie, Devauchelle-Pensec, Peter, Gergely, Xavier, Mariette, Raphael, Porcher, Marie, Wahren-Herlenius

Publikováno v: Annals of the Rheumatic Diseases, 81(7). BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases, 81, 189-190. BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases
Annals of the Rheumatic Diseases, 2022, pp.annrheumdis-2021-222054. ⟨10.1136/annrheumdis-2021-222054⟩
Annals of the Rheumatic Diseases, 2022, 81 (7), pp.979-989. ⟨10.1136/annrheumdis-2021-222054⟩

ObjectiveTo develop a composite responder index in primary Sjögren’s syndrome (pSS): the Sjögren’s Tool for Assessing Response (STAR).MethodsTo develop STAR, the NECESSITY (New clinical endpoints in primary Sjögren’s syndrome: an interventio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7c6311d86e6cf71758c555a5d4e7912
https://www.hal.inserm.fr/inserm-04030841

Zobrazit plný text záznamu

Development and testing of an alternative responder definition for EULAR Sjögren’s Syndrome Patient Reported Index (ESSPRI)

Autor: Samantha Wratten, Linda Abetz-Webb, Ethan Arenson, Pip Griffiths, Simon Bowman, Wolfgang Hueber, Briana Ndife, Daniel Kuessner, Pushpendra Goswami

Publikováno v: RMD Open. 9:e002721

ObjectivesDryness, fatigue and joint/muscle pain are typically assessed in Sjögren’s trials using European Alliance of Associations for Rheumatology Sjögren’s Syndrome Patient Reported Index (ESSPRI). A Patient Acceptable Symptom State of Metho

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::edf148a2b9c51a0f7852c7980c91046f
https://doi.org/10.1136/rmdopen-2022-002721

Zobrazit plný text záznamu

Akademický článek

Genomics and proteomics: Applications in autoimmune diseases

Autor: Wolfgang Hueber, William H Robinson

Publikováno v: Pharmacogenomics and Personalized Medicine, Vol 2009, Iss default, Pp 39-48 (2009)

Wolfgang Hueber1,2,3, William H Robinson1,21VA Palo Alto Health Care System, Palo Alto, CA, USA; 2Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, USA; 3Novartis Institutes of Biomedical Research, Novarti

Externí odkaz: https://doaj.org/article/00a1885436e0479ea1e785f10236a34c

Zobrazit plný text záznamu

IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis

Publikováno v: Journal of Allergy and Clinical Immunology. 144:750-763

Background Hyperactivity of the IL-23/IL-17 axis is central to plaque psoriasis pathogenesis. Secukinumab, a fully human mAb that selectively inhibits IL-17A, is approved for treatment of psoriasis, psoriatic arthritis, and ankylosing spondylitis. Se

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b90526d4e73be54560617fc2aa646c3
https://doi.org/10.1016/j.jaci.2019.04.029

Zobrazit plný text záznamu

Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sjögren's syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial

Autor: Robert J Moots, Athena Papas, Thomas Dörner, Benjamin A Fisher, Salvatore De Vita, Thomas Grader-Beck, Simon J. Bowman, Wolfgang Hueber, Monika Sopala, Filipe Barcelos, Hendrik Schulze-Koops, Guido Junge, Wen-Lin Luo, J. Woznicki, Robert I. Fox, Xavier Mariette

Publikováno v: Lancet (London, England). 399(10320)

Sjögren's syndrome is an autoimmune disease characterised by dry eyes and mouth, systemic features, and reduced quality of life. There are no disease-modifying treatments. A new biologic, ianalumab (VAY736), with two modes of suppressing B cells, ha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db757b875b597accf68e358402d7c023
https://pubmed.ncbi.nlm.nih.gov/34931061

Zobrazit plný text záznamu

POS0692 IANALUMAB (VAY736) SAFETY AND EFFICACY IN PATIENTS WITH SJOGREN’S SYNDROME: 52 WEEK RESULTS FROM A RANDOMISED, PLACEBO-CONTROLLED, PHASE 2B DOSE-RANGING TRIAL

Autor: Robert J Moots, Monika Sopala, Wolfgang Hueber, Xavier Mariette, S. De Vita, Wen-Lin Luo, Hendrik Schulze-Koops, Benjamin A Fisher, Guido Junge, Thomas Grader-Beck, Thomas Dörner, Simon J. Bowman, J. Woznicki, Filipe Barcelos, Athena Papas, Robert I. Fox

Publikováno v: Annals of the Rheumatic Diseases. 80:593-594

Background:Sjogren’s syndrome (SS) is an autoimmune disease affecting excretory glands and characterised by B-cell hyperactivity. Ianalumab (VAY736) is a human monoclonal antibody to B-cell activating factor receptor, engineered for direct ADCC-med

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0f97c15da11557d68b039f985c0e8605
https://doi.org/10.1136/annrheumdis-2021-eular.1700

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání